The latest research study “Monkeypox Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global monkeypox vaccine market size is expected to exhibit a CAGR of 14.90% during 2022-2027.

The monkeypox vaccine represents specialized biological preparations that help prevent the zoonotic viral disease caused by the monkeypox virus that belongs to the Orthropox genus from the Poxviridae family and can be transmitted through close contact with an infected person’s body fluids or contaminated items, such as respiratory droplets, bedding, lesions, etc. They can be categorized into two types, including replication-competent and replication-deficient. These monkeypox vaccine variants activate the immune system to produce antibodies against the virus and develop the natural defense system of the body so that it can make its own protection. They aid in containing the heightened need for hospitalization and mortality rate. Consequently, monkeypox vaccine formulations are extensively used in hospitals, clinics, and other healthcare facilities across the globe.

Request a Free PDF Sample for more detailed market insights:

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Monkeypox Vaccine Market Trends and Drivers:

The increasing cases of monkeypox infections across countries resulting in the declaration of a public health emergency by WHO are primarily driving the monkeypox vaccine market. Additionally, the rising investments in research and development (R&D) activities to introduce novel monkeypox vaccines and treatment drugs, such as the funding received by the UK Health Security Agency (UKHSA) and the UK Medicines and Healthcare Products Regulatory Agency (MHRA) from the Coalition for Epidemic Preparedness Innovations (CEPI) to support the innovation of laboratory tools for evaluating monkeypox vaccines are further catalyzing the market growth. Moreover, the launch of several initiatives by the government bodies aimed at spreading awareness among the masses about and the importance of immunization to ensure disease prevention, especially in endemic and rural areas, is acting as another significant growth-inducing factor. Besides this, the elevating adoption of genomic sequencing, which elucidates the specific infection-causing sequences and assists in the introduction of effective treatments, is expected to propel the monkeypox vaccine market in the coming years.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure:

Monkeypox Vaccine Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

The report has segmented the market on the basis of type, route of administration, distribution channel and end user.

Breakup by Type:

  • Replication-competent
  • Replication-deficient

Breakup by Route of Administration:

  • Subcutaneous
  • Percutaneous

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Contact Us:

IMARC Services Private Limited.

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.